
It’s High Time UK Life Insurance Companies Stopped Shafting Vape and Pouch Users
UK life insurance companies are charging vapers and nicotine pouch users the same high premiums as smokers, despite their use of far safer harm reduction products.

UK life insurance companies are charging vapers and nicotine pouch users the same high premiums as smokers, despite their use of far safer harm reduction products.
Latest

media watch
When people discuss unethical marketing by nicotine companies, it’s typically about the sort of packaging, colours, flavourings, or youth-targeting that reputable businesses keep well away from.

vaping
Age-gated vape devices are being promoted as a solution to youth vaping, but they may inconvenience adults and create more problems than they solve.

opinion
Is smoking really becoming cool again? A data-led breakdown of Gen Z trends, media hype, and why the narrative doesn’t match reality.

science
Does nicotine really boost IQ by 10 points? A breakdown of the evidence behind bold claims, cognitive effects, and what the research actually shows.

media watch
Media Watch unpacks a mouse nicotine study misreported as human risk, exposing how headlines exaggerate findings and distort scientific nuance.

politics
Alberta pushes Ottawa to loosen nicotine pouch rules. Premier Smith argues for wider access to harm reduction products and regulatory consistency with cigarettes.
Topic

media watch
A closer look at how misleading headlines and weak claims shape public perception of nicotine pouches, and why language games matter in harm reduction debates.
media watch
Kenya's tobacco control debate reveals a communication crisis. Sensible regulation gets lost in WHO-aligned prohibitionist rhetoric and conspiracy thinking.
media watch
Nicotine pouches caught in a political crossfire as Laura Loomer and Tucker Carlson battle over ALP, FDA violations, and excessive dosing claims.
Topic

opinion
Is heated tobacco advertising actually illegal in the UK? Analysis reveals legal ambiguity and challenges misleading public health claims in regulatory debate.
opinion
The WHO is urging governments to tax safer nicotine products like cigarettes, discouraging switching and risking higher smoking rates, disease, and death.
opinion
An investigation exposes how a Brussels NGO exaggerated claims of bot interference to dismiss public opposition to EU tobacco and vaping tax proposals.
Topic

information
Why a 20mg nicotine pouch cap makes sense. Strength arms races, retailer responsibility, and why “20 is plenty” protects consumers and harm reduction.
information
Ferrari’s 2026 F1 race suits will feature ZYN branding. Is this a tobacco throwback or a sign that smoke-free nicotine is entering the mainstream?
information
Slash’s journey from cigarettes to snus shows how reduced-risk nicotine can help people quit smoking and why adult access to alternatives matters.